Navigation Links
Keryx Biopharmaceuticals to Present at the Deutsche Bank 33rd Annual Health Care Conference
Date:5/5/2008

Presentation Scheduled for Wednesday, May 7th at 9:30am EDT

NEW YORK, May 5 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Michael S. Weiss, the Company's Chairman and Chief Executive Officer, is scheduled to present at the Deutsche Bank 33rd Annual Health Care Conference in Boston, Massachusetts.

Mr. Weiss' presentation, which will take place on Wednesday, May 7th at 9:30am EDT, will be webcast live and will be accessible from the Investor Information page of the Company's Website at http://investors.keryx.com. An archived version of the webcast will be available following the conclusion of the live presentation.

ABOUT KERYX BIOPHARMACEUTICALS, INC.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer. Keryx is developing Zerenex(TM) (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex is currently in Phase 2 clinical development for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease, or ESRD. The Company is also developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that modulates Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of other key signal transduction pathways, including the JNK and MAPK pathways, which are pathways associated with programmed cell death, cell growth, cell differentiation and cell surviva
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Keryx Biopharmaceuticals Receives Nasdaq Notification
2. Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
3. Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference
4. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
5. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
6. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
7. Keryx Biopharmaceuticals Announces Additions to Management Team
8. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
9. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
11. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... SAN DIEGO, Nov. 20 Veridiam (www.... the mid-size company category at the 2009 Workpla...the San Diego Society for Human Resources Manageme...resources practices. ,, Veridiam was one of nin...minated companies, honored at the recent awards ce...
(Date:11/20/2009)..., SEATTLE, Nov. 20 Ce... announced today that the Ninth Circuit Court of A...led that CTI should be allowed to pursue all of it...back to the District Court for trial. CTI filed a...ird-party reimbursement consultant for CTI,s produ...
(Date:11/19/2009)...COPENHAGEN, Nov. 19 Danish Prince ...llulosic ethanol plant in Kalundborg, Denmark, on ... world,s first and largest 2nd generation ethanol ...e enzymes are used in the plant,s innovative proce...ion of Danisco, was the first to market with comme...
(Date:11/19/2009)... NEW YORK, Nov. 19 NeoSt...it has sent the following letter to its shareholde...er 30, 2009, of China Biopharmaceuticals Holdings,...pany based in the People,s Republic of China. The ... Suzhou Eyre Pharmaceutical Co. Ltd., CHBP,s prima...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3
... experience a difficult time in securing conventio...h. But, for high-technology firms in located in th... of some creative regional business collaboration....ay Industrial Park Corporation, and Eau Claire Cou... pool. , ,The need of these businesses was illust...
...oundation (WARF) has completed a licensing agreem...blicly traded company (NYSE: MNT), which gives M...ghts to the proprietary botulinum toxin technology... In exchange, Mentor will pay WARF a royalty on sa...h payments at certain milestones in the regulatory...
...) Sarbanes-Oxley Act of 2002 (Sarbox), many public..., revised their financial recording and accounting...y people have asked whether privately held compani...equirements now imposed upon public companies. Are...x to privately held companies and non-profits appr...
Other Biology Technology:Eau Claire Pulls Together, Forms Million-Dollar Technology Loan Program 2Mentor Licenses Botulinum From WARF and Plans Wisconsin Manufacturing Facility 2Sarbanes-Oxley for the Rest of Us 2Sarbanes-Oxley for the Rest of Us 3Sarbanes-Oxley for the Rest of Us 4
(Date:11/19/2009)...ghly 15,000 years ago, at the end of the last ice ...als including such iconic creatures as mammoths, ... beavers began their precipitous slide to extinct...ing a land whose diversity of large animals equale...ains then or now, an entirely novel ecosystem emer...
(Date:11/19/2009)...s week, scientists are revealing the genetic instr...rops. Corn, or maize, has one of the most complex ... Wisconsin-Madison genomicist David Schwartz, who ... the journal Science . , "The maize genome is a...s that have troubled would-be sequencers for years...
(Date:11/19/2009)...s to corn, 1 + 1 = more than 2: The offspring of t...heir parents. Characterizing the gene-level variab...rosis or hybrid vigor, could boost our ability to ...igh protein content for human consumption or high ...rom the newly released DNA sequence of the common ...
Breaking Biology News(10 mins):After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3U of M plant scientist uncovers clues to yield-boosting quirks of corn genome 2DIA Conference to Explore Components of Risk Management Plans As They Apply to Medicinal Products Therapeutic Biologics and Vaccines 60773 1DIA Conference to Explore Components of Risk Management Plans As They Apply to Medicinal Products Therapeutic Biologics and Vaccines 60773 2DIA Conference to Explore Components of Risk Management Plans As They Apply to Medicinal Products Therapeutic Biologics and Vaccines 60773 3Local Medicare Advantage Plan Gets Five Star Ratings from Medicare 60771 1Local Medicare Advantage Plan Gets Five Star Ratings from Medicare 60771 2Local Medicare Advantage Plan Gets Five Star Ratings from Medicare 60771 3Americans United for Life 3A Rep Ellsworths Proposal Does Not Prevent Abortion Funding in Health Care Reform 60769 1
...c Ocean warms this century, shellfish, snails and ...n invasion of the northern Atlantic that was inter...go, predict Geerat Vermeij, professor of geology a...oopnarine at the California Academy of Sciences. ,...Ocean by 2050. That will restore conditions that l...
...ty of Houston department of health and human perfo...ruit 500 participants for a study promoting health... will take place entirely in the virtual world of ... part of the UH Texas Obesity Research Center,s (T... enjoyable way for participants to learn about pre...
...ous condition linked to chronic acid reflux often ...tter job intervening? Researchers from the Hutchin...In a review published in the inaugural issue of D...logists.org , experts on a disease known as "Barre...unique challenges in diagnosis and treatment. The...
Other Biology News:Pacific shellfish ready to invade Atlantic 2TORC at UH turns to virtual world of Second Life for new study 2Pre-cancerous condition linked to chronic acid reflux faces several hurdles 2
Goat Anti-Mouse Wnt-11 Polyclonal Antibodies, from R&D Systems
PEG 8000 Powder from Promega
Goat Anti-Mouse Iduronate 2-Sulfatase / IDS Affinity Purified Polyclonal Antibody, Unconjugated from R&D Systems
UCOM microplate photoactivator from Panomics
Biology Products: